← Warner Bros Discovery overview
Warner Bros Discovery IncWBD

Why is Warner Bros Discovery (WBD) moving?

Q3 2026
▼2▲1

WBD's merger saga ends with approval, but legal and financial risks persist

  • Merger approvals and financing secured EU and UK cleared the deal, Netflix made a bid, Paramount settled with states for $1.88bn, the FCC approved, and financing was secured. Streaming revenue topped $3bn. The merger is expected to close October 6 at $31 per share.

    These positive developments advanced the merger and supported WBD's value.

  • Legal challenges and regulatory delays Twelve states sued to block the deal, a federal judge paused it, California settlement talks collapsed, and Iowa and Montana sought Supreme Court intervention. These actions threatened to delay or kill the merger.

    These legal obstacles created uncertainty and risk for the merger's completion.

  • Weak Q2 financial results Q2 results missed badly: revenue fell 11% and net income plunged to $149 million. This weak performance raised concerns about WBD's standalone financial health.

    Poor financial results negatively impacted investor sentiment and WBD's value.

  • Post-close index removal may pressure shares After the merger closes, WBD may be removed from the Nasdaq 100 and other indices, which could temporarily push shares below $31. However, the $31 merger payout provides a floor for the stock.

    Index removal could cause short-term price weakness, but the merger payout limits downside.

September 2026
▲1▼1

Paramount merger nears close, WBD to exit indexes

  • Merger clears final hurdles The FCC waived foreign ownership limits, Paramount settled with 12 states, courts approved the settlement, and financing was fully secured. The deal is expected to close October 6, paying WBD holders $31 cash per share.

    This is the main new development that removes legal uncertainty and sets a firm payout for shareholders.

  • Index removal to pressure shares After closing, WBD will be removed from the Nasdaq 100 and other indexes, forcing index funds to sell shares. This could temporarily push the price below $31, though the merger payout sets a floor.

    This is a new risk that could affect the share price around the deal close.

Latest
▲3▼1

WBD merger clears final hurdles, set to close Oct 6

  • Court approval removes last legal block A federal judge approved the settlement with 12 states, clearing the antitrust lawsuit that had stalled Paramount's $111 billion purchase of WBD. This removes the final legal obstacle, making it almost certain the deal closes and WBD shareholders get paid.

    This is the key event that unlocks the merger and directly supports WBD's price near the offer.

  • Merger expected to close Oct 6 with $31 cash per share Paramount and WBD said the deal should close on October 6, with WBD shareholders receiving $31 in cash per share plus a small daily payment. This locks in the payout and removes uncertainty, pushing WBD's price toward the offer.

    It gives the exact closing date and payout, which is what investors need to know.

  • Financing fully priced and ready Paramount priced $41.4 billion in notes and an $8.5 billion loan to fund the purchase. The money is now secured, so there is no financing risk left to derail the deal, supporting WBD shares near the offer price.

    It shows the deal is fully funded, a key condition for closing.

  • Index removal will force selling WBD is being removed from the Nasdaq 100 and other major indexes as the merger closes. Index funds that track these indexes must sell their WBD shares, which can temporarily push the price down, though the merger payout still sets a floor.

    It is a new negative force that could pressure WBD's price in the short term.

▲3

Paramount clears final hurdles to buy WBD, financing underway

  • Paramount settles with 12 states, removing last major legal block Paramount agreed to settle with 12 states, including California, ending their antitrust lawsuit. The deal includes promises like CNN editorial independence. This removes the biggest remaining obstacle, making it much more likely the $110 billion takeover closes and WBD shareholders get paid.

    This is the key event that unlocks the deal and directly lifts WBD shares toward the offer price.

  • Paramount launches $49 billion debt sale to fund WBD purchase Bankers are selling $49 billion in bonds and loans to finance the takeover. Strong investor demand and approvals in nearly 70 countries mean the money is ready. This shows the deal is funded and on track, supporting WBD's price near the offer.

    Financing progress confirms the deal can close, reducing risk for WBD shareholders.

  • Paramount adds $7.5 billion loan to financing package Paramount launched a $7.5 billion secured loan as part of a larger $44.4 billion debt raise. The money will pay for the WBD acquisition and repay debt. This further locks in funding, making it more likely the deal completes and WBD investors receive the offer price.

    Additional financing reduces uncertainty and reinforces deal completion.

▲3▼1

FCC clears foreign ownership, but state lawsuit still blocks WBD deal

  • FCC approves foreign ownership in Paramount-WBD deal The FCC waived its 25% foreign ownership cap for Paramount's $110 billion purchase of WBD, clearing a key regulatory hurdle. This makes the deal more likely to close, which supports WBD shares near the offer price.

    This is a new, concrete regulatory approval that directly advances the merger and lifts deal certainty.

  • Settlement talks set for October 14-15 Paramount, California's attorney general, and the Writers Guild agreed to two days of settlement talks in October. A negotiated end to the lawsuit would remove the last major barrier, raising the chance the deal closes and supporting WBD.

    This is a new scheduled event that could resolve the main obstacle blocking the deal.

  • Paramount threatens to leave California if deal blocked Paramount is weighing moving its headquarters out of California if the merger is blocked, warning of job and economic losses. This raises political pressure but also signals the fight could drag on, keeping uncertainty high and WBD shares below the offer price.

    This new threat shows the conflict intensifying, which could delay or derail the deal and weigh on WBD.

  • Google in talks to license studio content for AI Google has approached WBD and other studios about licensing characters for AI models, with potential payments of $40 million per character. A deal could create a new revenue stream, but no agreement is reached and union sensitivities remain a hurdle.

    This new potential revenue source could add value to WBD's content library, though it is early-stage and uncertain.

August 2026
▲2▼1

Netflix bid and legal twists keep WBD deal in play

  • Netflix enters bidding for WBD studios Netflix joined the bidding for Warner Bros. Discovery's studios, competing with Paramount. This raised hopes of a higher offer price, lifting WBD shares early in the month.

    This new competitive bid directly boosted investor optimism about a better deal price.

  • California settlement talks collapse California canceled settlement talks with Paramount, accusing bad faith. This dashed hopes for a quick resolution, pushing WBD shares back below the $31 offer price.

    The collapse of talks removed a key path to closing the deal, weighing on the stock.

  • Paramount offers to settle with states Paramount proposed a settlement with 12 states, backed by a $1.88 billion bond, and Governor Newsom signaled support for a deal. This offered a possible way to end the legal fight.

    A potential settlement could remove a major legal hurdle and revive deal prospects.

  • Iowa and Montana seek Supreme Court intervention Iowa and Montana asked the Supreme Court to intervene in the merger case, adding legal uncertainty and delay risk. This keeps the deal's timeline unclear and pressures WBD shares.

    New legal challenges increase the chance of further delays, hurting deal certainty.

▲2▼2

WBD's fate hinges on settlement talks as legal fight drags on

  • California cancels settlement talks, raising deal risk California's attorney general canceled a settlement meeting with Paramount, accusing it of bad faith. This makes a quick resolution less likely, keeping WBD shares below the $31 offer price and increasing uncertainty.

    This is a key new development that directly affects the likelihood of the merger closing.

  • Newsom prefers settlement, offering a path forward Governor Newsom said he would prefer a settlement if it's a good deal, signaling political support for resolving the lawsuit. This could pressure the attorney general to settle, making the deal more likely and supporting WBD shares.

    This new statement provides a potential counterweight to the negative legal news and could help break the impasse.

  • Paramount seeks settlement and demands bond from states Paramount offered to settle with the 12 states and asked them to post a $1.88 billion bond. If the bond is required, it could pressure states to drop the lawsuit, increasing the chance the deal closes and lifting WBD.

    This is a new legal maneuver that could accelerate a resolution and reduce uncertainty.

  • Iowa and Montana take California to Supreme Court Two states filed a motion arguing that a handful of states are abusing antitrust law to block the deal. This adds legal uncertainty and could delay resolution, keeping WBD shares under pressure.

    This new legal challenge complicates the path to closing and highlights the ongoing risk.

▲3

Netflix bid and settlement hopes lift WBD as deal stays frozen

  • Netflix enters bidding war for WBD studios Netflix is now in a heated bid against Paramount for Warner Bros.' film and TV studios, drawn by DC Comics, Harry Potter and HBO. A second bidder can mean a higher price for WBD shareholders, pushing the stock up.

    A rival bidder is a new, major force that can raise the price WBD holders receive.

  • Paramount offers theaters a release guarantee Paramount offered AMC and Regal a three-year deal guaranteeing 30 theatrical releases a year if the WBD purchase closes. This could settle the states' antitrust lawsuit, making the deal more likely and supporting WBD shares.

    It is a new concrete step that could remove the main legal obstacle to the deal.

  • Hopes grow for a settlement with California WBD shares rose 1.6% on optimism that Paramount can settle with California's attorney general, who leads the states' lawsuit. A settlement would clear the last big hurdle, making the deal more likely to close and lifting WBD.

    It is a new development that directly affects the biggest remaining risk to the deal.

  • Paramount may sell CNN to clear the merger Paramount said it would sell CNN if that resolves the antitrust lawsuit. Selling an asset could help the deal close, but it also shows the legal fight is serious and the outcome is still uncertain, so the effect on WBD is mixed.

    It is a new possible remedy that cuts both ways for the deal's chances.

July 2026
▲2▼2

WBD deal faces state lawsuit and court pause, but EU/UK clear and streaming grows

  • Twelve states sue to block merger; federal judge pauses deal Twelve states sued to block the Paramount-WBD merger, and a federal judge paused it. Trial is set for March 2027, delaying closing until at least mid-2027 and keeping WBD shares below the $31 offer price.

    This is the main new negative event that pressures WBD's stock by delaying the deal.

  • EU and UK clear deal with conditions The EU and UK cleared the deal with conditions, removing major regulatory hurdles. Analysts expect HBO Max and Paramount+ to rival Netflix with $6bn in savings, supporting the deal's logic and WBD's value.

    This is a new positive regulatory development that advances the deal and supports WBD's price.

  • Streaming revenue tops $3bn for first time WBD's streaming revenue topped $3bn for the first time, showing growth in its direct-to-consumer business. This positive operational metric supports the company's standalone value and the deal's strategic rationale.

    This is a new positive fundamental data point that highlights WBD's streaming strength.

  • Q2 results miss badly; revenue down 11%, net income plunges Q2 results missed badly, with revenue down 11% and net income plunging to $149m. The weak financial performance adds pressure on WBD's stock and raises concerns about its standalone health.

    This is a new negative earnings event that weighs on WBD's price and investor sentiment.

▲2▼2

Deal clears UK/EU but US trial delay and weak Q2 weigh on WBD

  • UK regulator approves Paramount-WBD deal The UK competition authority cleared the $110 billion acquisition after Paramount offered binding guarantees on Channel 5 independence and UK programming. This removes a major regulatory hurdle, making the deal more likely to close and supporting WBD shares near the $31 offer price.

    This is a new regulatory approval that directly increases the chance the deal closes, a key price driver.

  • US antitrust trial set for March 2027, delaying deal A federal judge scheduled the states' lawsuit trial for March 2027, rejecting Paramount's request for November. The long delay keeps WBD shares below the $31 offer price and means Paramount must pay WBD shareholders about $7 million per day starting October 1.

    This new court date extends the deal timeline and triggers ticking fees, directly affecting WBD's price and shareholder payouts.

  • Q2 results miss estimates; net income plunges WBD's total revenue fell 11% to $8.72 billion, missing the $9.21 billion consensus, and net income dropped to $149 million from $1.58 billion due to write-downs and restructuring charges tied to the pending acquisition. Weak overall financials pressure the stock.

    This is new earnings data showing WBD's core business weakness, which weighs on investor sentiment and the stock price.

  • Streaming revenue tops $3 billion for first time WBD's streaming revenue rose 10% to over $3 billion, with HBO Max international expansion and hit series driving growth. The Disney bundle is reducing cancellations and improving subscriber additions, showing the streaming unit is becoming a profitable growth engine.

    This new milestone highlights a bright spot that could support WBD's valuation even as the deal faces delays.

▲2▼2

Deal blocked and suspended, but EU clears and breakup fee protects WBD

  • Judge temporarily blocks merger A federal judge froze the Paramount-WBD deal for 14 days on antitrust grounds, with a hearing set for August 3. This makes it less likely the deal closes soon, pushing WBD shares below the $31 offer price.

    This is the first court-ordered block, a major new legal hurdle that directly threatens deal completion.

  • EU approves deal with conditions The European Union cleared the $110 billion acquisition after Paramount agreed to unwind a film distribution joint venture. This removes a key regulatory obstacle, making the deal more likely to eventually close and supporting WBD shares.

    EU approval is a new positive regulatory step that contrasts with US legal challenges.

  • Merger suspended until at least mid-2027 Paramount and WBD agreed to pause the deal until five days after key court rulings or June 1, 2027. This long delay keeps WBD shares below the offer price and increases uncertainty, though it also triggers extra per-share payments.

    The formal suspension is a new development that extends the timeline and adds pressure on WBD shares.

  • Breakup fee and Ellison guarantee protect WBD If the deal collapses, WBD gets a $7 billion termination fee, and Larry Ellison personally guarantees $40.4 billion. This financial backstop limits downside for WBD shareholders, even as Oracle stock drops.

    The guarantee and fee details are new and provide a safety net that supports WBD's value.

▼3▲1

WBD deal faces state lawsuit and UK/EU scrutiny, but analysts still see it closing

  • UK government moves to intervene in the takeover Britain's culture secretary said she is 'minded to intervene' in Paramount's £83bn purchase of WBD, citing media plurality concerns, and may order deeper scrutiny by Ofcom and the competition authority. A UK block or long delay would push WBD shares below the $31 offer price.

    A new regulator joining the review adds a real path to delay or block the deal, which is the main force on WBD's price.

  • Twelve states sue to block the merger; judge to rule by July 22 Attorneys general led by California filed an antitrust lawsuit to stop the deal, and a federal judge will decide by July 22 on a temporary halt. If the deal slips past September 30, Paramount must pay WBD holders an extra 25 cents per share per quarter, about $650 million.

    This is the biggest new legal threat to closing and directly affects how much WBD shareholders get and when.

  • Analysts say the lawsuit delays but won't derail the deal Needham's Laura Martin called the states' arguments outdated and politically driven, expecting delay rather than a kill. Morgan Stanley sees the combined HBO Max/Paramount+ becoming a must-have streamer rivaling Netflix, with $6bn of cost savings and leverage falling below three times in three years.

    It is the main counterweight: if the deal still closes, WBD's stock should keep gravitating toward the $31 offer.

  • Deal closing pushed back; EU deadline extended to July 22 Paramount told Oregon officials it won't complete the WBD purchase before July 22, and the EU extended its decision deadline to the same date after Paramount offered concessions, including unwinding a film distribution joint venture. Each delay keeps WBD shares below the offer price and raises the chance of extra per-share payments.

    The slipping timetable is the concrete new evidence that the deal is taking longer and costing more.

Q2 2026
▲3▼1

WBD's $110B Paramount takeover clears key hurdles, but state and UK reviews remain

  • China and EU regulatory approvals advance the deal China approved Paramount's $110 billion purchase of WBD, and the EU is set to clear it with minor remedies. These approvals remove major obstacles, making the deal more likely to close and pushing WBD's stock toward the $31 offer price.

    Regulatory clearances directly increase the probability of the deal closing, which is the main driver of WBD's stock price.

  • California and states prepare antitrust lawsuit to block the deal California is considering hiring lawyers for a multistate lawsuit to block the merger, even though the DOJ approved it. A state lawsuit could delay or kill the deal, which would likely cause WBD shares to fall from the offer price.

    This is a key remaining risk that could prevent the deal from closing, directly threatening the merger arbitrage spread.

  • Arbitrageurs say deal odds are too low, pointing to upside Traders note the market implies only a 70% chance of the deal closing, but they think it's much higher. The gap between WBD's stock and Paramount's $31 offer is $4.76, offering potential profit if the deal completes, which supports WBD's price.

    This explains why WBD's stock may be undervalued relative to the deal price, a direct force on its market value.

  • Options bet on deal closing before July 24 A large options trade suggests a 30% chance the deal closes before July 24, earlier than expected. If the deal closes sooner, WBD shares could jump to the $30 level, making this a bullish signal for the stock.

    This shows market expectations for the timing of the deal, which affects WBD's price as the target.

June 2026
▲3▼1

WBD's $110B Paramount takeover clears key hurdles, but state and UK reviews remain

  • China and EU regulatory approvals advance the deal China approved Paramount's $110 billion purchase of WBD, and the EU is set to clear it with minor remedies. These approvals remove major obstacles, making the deal more likely to close and pushing WBD's stock toward the $31 offer price.

    Regulatory clearances directly increase the probability of the deal closing, which is the main driver of WBD's stock price.

  • California and states prepare antitrust lawsuit to block the deal California is considering hiring lawyers for a multistate lawsuit to block the merger, even though the DOJ approved it. A state lawsuit could delay or kill the deal, which would likely cause WBD shares to fall from the offer price.

    This is a key remaining risk that could prevent the deal from closing, directly threatening the merger arbitrage spread.

  • Arbitrageurs say deal odds are too low, pointing to upside Traders note the market implies only a 70% chance of the deal closing, but they think it's much higher. The gap between WBD's stock and Paramount's $31 offer is $4.76, offering potential profit if the deal completes, which supports WBD's price.

    This explains why WBD's stock may be undervalued relative to the deal price, a direct force on its market value.

  • Options bet on deal closing before July 24 A large options trade suggests a 30% chance the deal closes before July 24, earlier than expected. If the deal closes sooner, WBD shares could jump to the $30 level, making this a bullish signal for the stock.

    This shows market expectations for the timing of the deal, which affects WBD's price as the target.

▲3▼1

WBD's $110B Paramount takeover clears key hurdles, but state and UK reviews remain

  • China and EU regulatory approvals advance the deal China approved Paramount's $110 billion purchase of WBD, and the EU is set to clear it with minor remedies. These approvals remove major obstacles, making the deal more likely to close and pushing WBD's stock toward the $31 offer price.

    Regulatory clearances directly increase the probability of the deal closing, which is the main driver of WBD's stock price.

  • California and states prepare antitrust lawsuit to block the deal California is considering hiring lawyers for a multistate lawsuit to block the merger, even though the DOJ approved it. A state lawsuit could delay or kill the deal, which would likely cause WBD shares to fall from the offer price.

    This is a key remaining risk that could prevent the deal from closing, directly threatening the merger arbitrage spread.

  • Arbitrageurs say deal odds are too low, pointing to upside Traders note the market implies only a 70% chance of the deal closing, but they think it's much higher. The gap between WBD's stock and Paramount's $31 offer is $4.76, offering potential profit if the deal completes, which supports WBD's price.

    This explains why WBD's stock may be undervalued relative to the deal price, a direct force on its market value.

  • Options bet on deal closing before July 24 A large options trade suggests a 30% chance the deal closes before July 24, earlier than expected. If the deal closes sooner, WBD shares could jump to the $30 level, making this a bullish signal for the stock.

    This shows market expectations for the timing of the deal, which affects WBD's price as the target.

© 2026 MarketDXWhy